All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-0120ZP1907 | Anti-SLC45A3 (DS3304AB) h(CD28-CD3ζ) CAR, pCDCAR1 | Rabbit | DS3304AB | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1908 | Anti-SLC45A3 (DS3304AB) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Rabbit | DS3304AB | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1909 | Anti-SLC45A3 (11F4) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | 11F4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1910 | Anti-SLC45A3 (11F4) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Mouse | 11F4 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1911 | Anti-SLC45A3 (ZR9) h(CD28-CD3ζ) CAR, pCDCAR1 | Rabbit | ZR9 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1912 | Anti-SLC45A3 (ZR9) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Rabbit | ZR9 | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1913 | Anti-SLC45A3 (CBXS-5754) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | CBXS-5754 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1914 | Anti-SLC45A3 (CBXS-5754) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Mouse | CBXS-5754 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1915 | Anti-SLC45A3 (G-9) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | G-9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
XS-0622-ZP3281 | Anti-SLC45A3 h(VHH1-VHH2-CD28-CD3ζ) Biepitopic CAR, pCDCAR1 | Human | VHH1-VHH2-CD28-CD3ζ | Lentiviral vector | T Cell | ||||
XS-0622-ZP3453 | Anti-SLC45A3 h(VHH1-VHH2-4-1BB-CD3ζ) Biepitopic CAR, pCDCAR1 | VHH1-VHH2-4-1BB-CD3ζ | Lentiviral vector | T Cell | |||||
XS-0822-YF817 | Anti-Human SLC45A3 (XW-817) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-817 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF818 | Anti-Human SLC45A3 (XW-818) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-818 | Rabbit | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF819 | Anti-Mouse SLC45A3 (XW-819) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-819 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1737 | Anti-Human SLC45A3 (XW-817) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-817 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1738 | Anti-Human SLC45A3 (XW-818) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-818 | Rabbit | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1739 | Anti-Mouse SLC45A3 (XW-819) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-819 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2657 | Anti-Human SLC45A3 (XW-817) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-817 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2658 | Anti-Human SLC45A3 (XW-818) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-818 | Rabbit | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2659 | Anti-Mouse SLC45A3 (XW-819) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-819 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION